Single-dose eculizumab as part of a modified desensitization protocol for ABO-incompatible living donor liver transplantation
Single-dose eculizumab as part of a modified desensitization protocol for ABO-incompatible living donor liver transplantation is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Single-dose eculizumab as part of a modified desensitization protocol for ABO-incompatible living donor liver transplantation have?
Single-dose eculizumab as part of a modified desensitization protocol for ABO-incompatible living donor liver transplantation has 3 citations in the OpenAlex counts ScholarIQ stores.
When was Single-dose eculizumab as part of a modified desensitization protocol for ABO-incompatible living donor liver transplantation published?
Single-dose eculizumab as part of a modified desensitization protocol for ABO-incompatible living donor liver transplantation has 2023 year in the ScholarIQ index.
What is the open-access status of Single-dose eculizumab as part of a modified desensitization protocol for ABO-incompatible living donor liver transplantation?
Single-dose eculizumab as part of a modified desensitization protocol for ABO-incompatible living donor liver transplantation has closed oa status in the ScholarIQ index.
What is the DOI of Single-dose eculizumab as part of a modified desensitization protocol for ABO-incompatible living donor liver transplantation?
The DOI for Single-dose eculizumab as part of a modified desensitization protocol for ABO-incompatible living donor liver transplantation is on the source record.
What is the PMID of Single-dose eculizumab as part of a modified desensitization protocol for ABO-incompatible living donor liver transplantation?
The PMID for Single-dose eculizumab as part of a modified desensitization protocol for ABO-incompatible living donor liver transplantation is on the source record.
What is the OpenAlex record for Single-dose eculizumab as part of a modified desensitization protocol for ABO-incompatible living donor liver transplantation?
The OpenAlex for Single-dose eculizumab as part of a modified desensitization protocol for ABO-incompatible living donor liver transplantation is on the source record.